Mycetoma affecting the foot is a chronic, progressively destructive infection that usually begins after traumatic implantation of bacteria or fungi into skin and soft tissue. It commonly presents with a painless swelling of the foot, sinus tracts that drain pus, and visible “grains” in the discharge, and if diagnosis is delayed it can invade bone and lead to severe deformity or amputation
Mycetoma is an important tropical and subtropical disease because it often affects people who work barefoot in rural environments and may not seek care until the disease is advanced. The foot is the classic site of infection, likely because it is frequently exposed to thorn pricks, splinters, and other minor penetrating injuries that introduce organisms from soil or plant matter into deeper tissues. Although the disease is not common in many parts of the world, it has major consequences for mobility, work capacity, and quality of life. For a condition that often starts quietly, its later effects can be devastating.
Cause and transmission
Mycetoma is caused by either bacteria or fungi, which leads to two broad forms: actinomycetoma and eumycetoma. The organisms are usually environmental, living in soil, water, or plant material, and infection typically follows a break in the skin rather than person-to-person spread. Minor injuries such as stepping on a thorn or wood splinter are classic triggers, especially in settings where shoes are not regularly worn. The disease is therefore closely tied to occupation, poverty, and limited access to preventive footwear and healthcare. This makes mycetoma more than an infection; it is also a marker of social vulnerability.
Clinical features
The hallmark of foot mycetoma is a slowly enlarging, usually painless swelling that may persist for months or years before diagnosis. Over time, the lesion can develop multiple draining sinuses that discharge thick material containing tiny grains, which may be white, yellow, red, brown, or black depending on the causative organism. Because pain is often minimal, many patients continue walking and working while the lesion gradually expands. As the disease progresses, the foot may become distorted, stiff, or functionally unusable, and secondary bacterial infection can complicate the picture. In advanced cases, underlying muscle, tendons, and bone may be destroyed.
Diagnosis
Diagnosis of foot mycetoma depends on a combination of clinical suspicion, imaging, and laboratory confirmation. A careful history of barefoot exposure, thorn injury, rural work, and very slow progression should raise suspicion early. Imaging such as ultrasound or X-ray can help assess the extent of soft tissue involvement and detect bone invasion, while biopsy, aspiration, or examination of the grains can identify the organism. This distinction matters because actinomycetoma and eumycetoma require different treatment approaches. Delayed diagnosis is common because the condition may mimic chronic abscesses, osteomyelitis, or other granulomatous foot disorders.
Treatment
Treatment depends on whether the infection is bacterial or fungal. Actinomycetoma usually responds better to prolonged antibiotic therapy, while eumycetoma generally requires long-term antifungal treatment, often with itraconazole or related agents. Surgery may be needed when there is extensive local disease, failure of medical therapy, or significant bone involvement. In late or severe cases, bone resection or even amputation may be required to control the infection and preserve overall function. Because treatment is prolonged and relapses can occur, adherence and follow-up are essential. Outcomes are best when the disease is caught before major tissue destruction has occurred.
Public health impact
Foot mycetoma has a disproportionate effect on people in endemic regions of Africa, Latin America, and Asia, especially farmers, herders, and other outdoor workers. The disease can cause long-term disability, lost income, and stigma, particularly when deformity becomes visible. Prevention is therefore straightforward in principle but difficult in practice: wearing protective shoes, promptly cleaning wounds, and seeking early evaluation after penetrating foot injuries can reduce risk. However, these measures are harder to implement where poverty, remote geography, and limited healthcare access persist. This is one reason mycetoma is recognized as a neglected tropical disease
Conclusion
Mycetoma of the foot is a chronic infection that begins innocently but can become highly destructive if not recognized early. Its classic triad of painless swelling, draining sinuses, and grains in discharge should prompt urgent evaluation, especially in people from endemic regions or those with barefoot exposure. Because treatment differs for bacterial and fungal disease, accurate diagnosis is critical, and early therapy offers the best chance of preventing deformity, disability, and amputation. In clinical practice, the key challenge is not just treating mycetoma, but diagnosing it before the foot is irreversibly damaged.